Thorne HealthTech

Thorne HealthTech, Inc. is engaged in the provision of a total system for wellness. It utilizes testing and data to create improved product quality and deliver personalized solutions to consumers, health professionals, and professional sports teams. It also helps pharmaceutical and biotechnology companies repurpose existing drugs and compounds, improve existing medications and develop new products. The company was founded by Paul Jacobson in 2010 and is headquartered in New York, NY.

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Thorne reports strong Q1 performance, eyes international expansion and new product launches

Thorne's Q1 2023 earnings call highlighted its strong operating performance, unique positioning in personalized wellness, and key accomplishments, including positive trial results and recognition as an innovative company. While facing challenges related to profitability and manufacturing, the company is focused on leveraging opportunities in international markets and expanding its product offerings.

THRN reports record Q2 sales and product achievements, faces analyst inquiries

THRN's Q2 2023 earnings call showcased strong sales growth, margin improvement, and notable product achievements. However, questions from analysts highlighted areas of uncertainty and the need for clarity on future growth drivers. The company's expansion plans and marketing initiatives present opportunities for continued success.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow